EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+25.68%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$270M
AUM Growth
+$270M
(+25%)
Cap. Flow
+$38.6M
Cap. Flow
% of AUM
14.28%
Top 10 Holdings %
Top 10 Hldgs %
73.27%
Holding
33
New
7
Increased
6
Reduced
8
Closed
4
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$23.7M |
| 2 |
Kura Oncology
KURA
|
$20.6M |
| 3 |
Cytokinetics
CYTK
|
$14.8M |
| 4 |
Galapagos
GLPG
|
$10.5M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$9.52M |
Top Sells
| 1 |
Atara Biotherapeutics
ATRA
|
$25.3M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$12.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$7.11M |
| 4 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$2.59M |
| 5 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$1.98M |
Sector Composition
| 1 | Healthcare | 84.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
26
DELISTED
Regulus Therapeutics
RGLS
| – | – |
0
| – | – |
|
|
CASC
27
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
-943,500
| Closed | -$2.59M |
|
|
OREX
28
DELISTED
Orexigen Therapeutics, Inc.
OREX
| – | – |
-937,958
| Closed | -$1.98M |
|
|
29
Atara Biotherapeutics
ATRA
$88.7M
| – | – |
-803,458
| Closed | -$25.3M |
|
30
Bausch Health
BHC
$2.72B
| – | – |
0
| – | – |
|
31
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|
32
Gyre Therapeutics
GYRE
$734M
| – | – |
-56,000
| Closed | -$261K |
|